港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

维立志博-B

67.100

+32.10091.71%

成交量：3,311.83万

成交额：23.49亿

市值：129.50亿

市盈率：-38.90

高：79.600

开：72.400

低：67.100

收：35.000

数据加载中...

总览公司新闻公告

新股定价 | 维立志博-B上限定价，公开发售超购3493倍，一手中签率0.27%、抽400手稳获一手

老虎资讯综合

港股IPO动态：今日维立志博上市

维立志博-B(09887.HK)最终每股发售价35港元香港公开发售获3494.78倍认购

新股暗盘 | 维立志博-B(09887.HK)暗盘收涨100.14% 每手赚3505港元

新股暗盘 | 维立志博-B(09887)暗盘盘初涨超95% 每手赚3335港元

老虎暗盘｜维立志博-B飙涨100%，股价站上70港元！中签一手赚3500港元

老虎资讯综合

维立志博-B认购火爆！孖展申购倍数近2400倍，申购额近2700亿港元

老虎资讯综合

维立志博招股首日认购近179倍；奥克斯二度递表港交所丨港交所早参

每日经济新闻

太火爆！维立志博招股首日超购295倍

维立志博启动招股：预计募资10.7亿港元于7月25日上市，正心谷、高毅、易方达基金等担任基石投资者

新浪港股-好仓工作室

【新股IPO】维立志博-B(09887)今日起招股入场费3,535.30港元

新股招股｜维立志博-B今起招股，一手入场费约3535.3港元

老虎资讯综合

维立志博-B(09887)于7月17日至7月22日招股，拟全球发售3205.44万股H股

智通财经网

药企“卖青苗”是贱卖资产吗？资深律师解析创新药BD交易背后的隐秘博弈：“报价优渥”的交易并不总是最佳选择

每日经济新闻

四成半IPO募资超1亿美元，上半年44家香港上市、募资1071亿 | 香港IPO市场2025年

瑞恩资本Ryanbe...

维立志博通过港交所聆讯，业绩持续亏损

211家公司排队港股IPO！超八成为首次递表，A股公司纷纷赴港交表

一图解码：港股IPO一周回顾递表情绪高涨单日递表量达16家

IPO周报｜本周1只新股申购，创业板迎电子树脂头部供应商

维立志博上市聆讯获通过

微博财经-财道工作室

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/09887/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"09887","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09887\",,,,,undefined,":{"symbol":"09887","market":"HK","secType":"STK","nameCN":"维立志博-B","latestPrice":67.1,"timestamp":1753430887036,"preClose":35,"halted":0,"volume":33118341,"delay":0,"floatShares":148000000,"shares":193000000,"eps":-1.725,"marketStatus":"休市中","change":32.1,"latestTime":"07-25 16:08:07","open":72.4,"high":79.6,"low":67.1,"amount":2349489336,"amplitude":0.357143,"askPrice":67.4,"askSize":100,"bidPrice":67.1,"bidSize":700,"shortable":0,"etf":0,"ttmEps":-1.651777067,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753666200000},"marketStatusCode":7,"adr":0,"listingDate":1753372800000,"exchange":"SEHK","adjPreClose":35,"openAndCloseTimeList":[[1753407000000,1753416000000],[1753419600000,1753430400000]],"volumeRatio":0,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09887\",,,,,undefined,":{"symbol":"09887","floatShares":148000000,"roa":"--","roe":"--","lyrEps":-1.725,"shares":193000000,"dividePrice":0,"high":79.6,"amplitude":0.357143,"preClose":35,"low":67.1,"week52Low":67.1,"pbRate":"61.40","week52High":79.6,"institutionHeld":0,"latestPrice":67.1,"committee":0.75,"eps":-1.725,"divideRate":0,"volume":33118341,"delay":0,"ttmEps":-1.651777067,"open":72.4,"prevYearClose":35,"prevWeekClose":35,"prevMonthClose":35,"prevQuarterClose":35,"fiveDayClose":35,"twentyDayClose":35,"sixtyDayClose":35},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"09887\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1135478411","title":"新股定价 | 维立志博-B上限定价，公开发售超购3493倍，一手中签率0.27%、抽400手稳获一手","url":"https://stock-news.laohu8.com/highlight/detail?id=1135478411","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135478411?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 07:21","pubTimestamp":1753399314,"startTime":"0","endTime":"0","summary":" $维立志博-B(09887)$ (09887)公布招股结果，上限定价35港元，集资总额约12.9亿港元，净额约11.79亿港元。每手100股，一手中签率0.27%，认购400手才可稳获一手。甲组尾至少获2手，头槌飞最多获16手。公开发售共接获323,706份有效申请，当中73,406份获受理，超购3,493.78倍，触发回拨机制，令发售比例升至43.48%。国际发售有141名承配人，超购39.78倍。维立志博今日（25日）挂牌。维立志博计划发行3205.4万股H股，一成于香港作公开发售，每股招股价介乎31.6至35元，集资最多11.2亿元。摩根士丹利、中信証券为联席保荐人。","market":"us","thumbnail":"https://community-static.tradeup.com/news/146b5ed11cb8a15915eed9fdbdf4b318","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/146b5ed11cb8a15915eed9fdbdf4b318"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2be6df3677c49ea3193469949bfbb28d","theme_name":"🔥热榜No.6 · 中国TCE第一股维立志博在港交所挂牌上市","theme_type":2,"isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"维立志博-B上限定价，公开发售超购3493倍，一手中签率0.27%、抽400手稳获一手","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09887"],"gpt_icon":0},{"id":"2554735255","title":"港股IPO动态：今日维立志博上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2554735255","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554735255?lang=zh_cn&edition=fundamental","pubTime":"2025-07-25 06:10","pubTimestamp":1753395031,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"0fda2cb56104638865dda6383d751092","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["09887"],"gpt_icon":0},{"id":"2553789617","title":"维立志博-B(09887.HK)最终每股发售价35港元 香港公开发售获3494.78倍认购","url":"https://stock-news.laohu8.com/highlight/detail?id=2553789617","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553789617?lang=zh_cn&edition=fundamental","pubTime":"2025-07-24 22:46","pubTimestamp":1753368398,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"0fda2cb56104638865dda6383d751092","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["09887"],"gpt_icon":0},{"id":"2553240201","title":"新股暗盘 | 维立志博-B(09887.HK)暗盘收涨100.14% 每手赚3505港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553240201","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553240201?lang=zh_cn&edition=fundamental","pubTime":"2025-07-24 18:39","pubTimestamp":1753353586,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"0fda2cb56104638865dda6383d751092","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["09887"],"gpt_icon":0},{"id":"2553277327","title":"新股暗盘 | 维立志博-B(09887)暗盘盘初涨超95% 每手赚3335港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553277327","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553277327?lang=zh_cn&edition=fundamental","pubTime":"2025-07-24 16:16","pubTimestamp":1753345018,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，维立志博-B(09887)将于7月25日(周五)在香港挂牌。截至发稿，暗盘交易显示报价68.35港元，较招股价35港元上涨95.29%，每手100股，不计手续费，每手赚3335港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"0fda2cb56104638865dda6383d751092","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1321483.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09887"],"gpt_icon":0},{"id":"1194189978","title":"老虎暗盘｜维立志博-B飙涨100%，股价站上70港元！中签一手赚3500港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1194189978","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194189978?lang=zh_cn&edition=fundamental","pubTime":"2025-07-24 16:15","pubTimestamp":1753344946,"startTime":"0","endTime":"0","summary":"7月24日，生物科技公司$维立志博-B(09887)$暗盘开张40%，报48港元/股，总市值超76亿港元；不计手续费，中签一手赚1300港元；公司每股定价35港元，每手100股，将于7月25日（周五）正式挂牌交易。维立志博-B此前认购火爆，孖展超购逾3029倍，位于今年来新股认购倍数榜第5位；公司冻资近3400亿港元，同样位居今年来新股冻资榜第5位。","market":"hk","thumbnail":"https://static.tigerbbs.com/e2bc484766922e67d87fdb952e5532ab","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e2bc484766922e67d87fdb952e5532ab"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"0fda2cb56104638865dda6383d751092","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09887"],"gpt_icon":0},{"id":"1145589802","title":"维立志博-B认购火爆！孖展申购倍数近2400倍，申购额近2700亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1145589802","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145589802?lang=zh_cn&edition=fundamental","pubTime":"2025-07-21 18:00","pubTimestamp":1753092000,"startTime":"0","endTime":"0","summary":"7月21日，生物科技公司$维立志博-B$认购火爆！截止发稿，孖展申购倍数近2400倍，申购额近2700亿港元。此前该公司公告拟全球发售3205.44万股H股，其中，香港发售占10%，国际发售占90%。公司已与基石投资者LVC实体、高毅实体 、TruMed、OrbiMed、Huang River Investment Limited、易方达基金、Foresight Funds、Sage Partners及汉康实体订立基石投资协议，基石投资者已同意在若干条件的规限下，按发售价认购或促使其指定实体认购可购入有关数目的发售股份，总金额为6900万美元。","market":"hk","thumbnail":"https://static.tigerbbs.com/6b69e234a63c2c0a69ccede7b0faaa18","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6b69e234a63c2c0a69ccede7b0faaa18"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09887"],"gpt_icon":1},{"id":"2552330444","title":"维立志博招股首日认购近179倍；奥克斯二度递表港交所丨港交所早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2552330444","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552330444?lang=zh_cn&edition=fundamental","pubTime":"2025-07-18 00:30","pubTimestamp":1752769853,"startTime":"0","endTime":"0","summary":"｜2025年7月18日星期五｜NO.1维立志博招股首日认购近179倍7月17日，维立志博-B（HK02617）正式在港交所启动招股，招股截至7月22日，预计于7月25日在港交所挂牌上市。该公司专注于发现、开发和商业化治疗肿瘤、自身免疫性疾病以及其他严重疾病的新疗法。其招股价为31.6港元至35港元，拟全球发售3205.44万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202507183460298531.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202507183460298531.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["09887","BK1229","BK1258","02080"],"gpt_icon":0},{"id":"2552543202","title":"太火爆！维立志博招股首日超购295倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2552543202","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552543202?lang=zh_cn&edition=fundamental","pubTime":"2025-07-17 21:15","pubTimestamp":1752758100,"startTime":"0","endTime":"0","summary":"维立志博本次IPO发行股份占全部股份比例的17%，按招股价上限35港元算，募资约11.22亿港元，9名基石投资者锁定5.42亿，流通盘5.8亿。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-07-17/doc-inffuvpk4981155.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["09887"],"gpt_icon":1},{"id":"2552517407","title":"维立志博启动招股：预计募资10.7亿港元于7月25日上市，正心谷、高毅、易方达基金等担任基石投资者","url":"https://stock-news.laohu8.com/highlight/detail?id=2552517407","media":"新浪港股-好仓工作室","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552517407?lang=zh_cn&edition=fundamental","pubTime":"2025-07-17 09:53","pubTimestamp":1752717180,"startTime":"0","endTime":"0","summary":"　　7月17日，南京维立志博生物科技股份有限公司启动招股，股票代码为9887，预计于2025年7月25日在港交所上市。　　集团已订立基石投资协议，据此，基石投资者已同意在若干条件的规限下，按发售价认购或促使其指定实体认购可购入有关数目的发售股份，总金额为6900万美元。　　维立志博成立于2012年，是一家临床阶段生物科技公司，专注于肿瘤、自身免疫性疾病及其他重大疾病新疗法的发现、开发及商业化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigc/ggxg/qdfx/2025-07-17/doc-inffttzw0378890.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["09887"],"gpt_icon":1},{"id":"2552117963","title":"【新股IPO】维立志博-B(09887)今日起招股 入场费3,535.30港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552117963","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552117963?lang=zh_cn&edition=fundamental","pubTime":"2025-07-17 08:33","pubTimestamp":1752712438,"startTime":"0","endTime":"0","summary":"金吾财讯 | 维立志博-B 今日起招股，拟发行3205.44万股H股，其中90%为国际发售；10%为香港发售，另有15%超额配股权。每股招股价介于31.6港元-35港元，每手100股，入场费3,535.30港元。股份预期将于7月25日挂牌上市。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250107/MjI2MDllNmU0MDE4OTQyNzM4NTczYjJhMDY4OTU0MjU2ODIwNTMx.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/MjI2MDllNmU0MDE4OTQyNzM4NTczYjJhMDY4OTU0MjU2ODIwNTMx.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1962385","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09887"],"gpt_icon":0},{"id":"1188777047","title":"新股招股｜维立志博-B今起招股，一手入场费约3535.3港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1188777047","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188777047?lang=zh_cn&edition=fundamental","pubTime":"2025-07-17 06:53","pubTimestamp":1752706395,"startTime":"0","endTime":"0","summary":"7月17日，$维立志博-B$于7月17日至2025年7月22日招股，该公司拟全球发售3205.44万股H股，其中，香港发售占10%，国际发售占90%。每股发售股份31.6港元-35.0港元，每手100股，预期H股将于7月25日开始在联交所买卖。申购阶梯：每手100股，入场费3535.3港元。乙组门槛为20万股，申购所需资金约707.06万港元。","market":"hk","thumbnail":"https://static.tigerbbs.com/6b69e234a63c2c0a69ccede7b0faaa18","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6b69e234a63c2c0a69ccede7b0faaa18"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"新股招股｜维立志博-B今起招股，一手入场费约3535.3港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09887"],"gpt_icon":1},{"id":"2552175961","title":"维立志博-B(09887)于7月17日至7月22日招股，拟全球发售3205.44万股H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2552175961","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552175961?lang=zh_cn&edition=fundamental","pubTime":"2025-07-17 06:41","pubTimestamp":1752705660,"startTime":"0","endTime":"0","summary":"维立志博-B于2025年7月17日至2025年7月22日招股，该公司拟全球发售3205.44万股H股，其中，香港发售占10%，国际发售占90%。每股发售股份31.6港元-35.0港元，每手100股，预期H股将于2025年7月25日(星期五)开始在联交所买卖。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkstocknews/2025-07-17/doc-infftptt3881678.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["09887"],"gpt_icon":0},{"id":"2550998669","title":"药企“卖青苗”是贱卖资产吗？资深律师解析创新药BD交易背后的隐秘博弈：“报价优渥”的交易并不总是最佳选择","url":"https://stock-news.laohu8.com/highlight/detail?id=2550998669","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2550998669?lang=zh_cn&edition=fundamental","pubTime":"2025-07-12 09:05","pubTimestamp":1752282315,"startTime":"0","endTime":"0","summary":"2025年以来，创新药板块强势突围，成为成长赛道中的最大“黑马”。Wind数据显示，截至7月9日，全市场成立满一年的963只ETF中，仅有7只实现业绩翻倍，港股创新药ETF（513120）便是其中之一，该基金近一年来的收益率达到103%（截至7月11日）。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202507123455263034.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202507123455263034.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","BK1161","06978","09887"],"gpt_icon":0},{"id":"2548636793","title":"四成半IPO募资超1亿美元，上半年44家香港上市、募资1071亿 | 香港IPO市场2025年","url":"https://stock-news.laohu8.com/highlight/detail?id=2548636793","media":"瑞恩资本Ryanbe...","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548636793?lang=zh_cn&edition=fundamental","pubTime":"2025-07-04 13:22","pubTimestamp":1751606520,"startTime":"0","endTime":"0","summary":"2025年上半年，香港新上市公司共44家，募资1070.61亿，新上市数量较上年同期增14家，募资金额按年增加937亿或 7.01倍。其中的3家已获上市委员会批准除牌。2025年上半年通过IPO上市的42家上市公司一共募资1070.61亿，较2024年同期增加 937亿或701.3%，主要原因是香港IPO市场开始大力回暖、以及越来越多的大型A股公司赴港上市。其中，募资超过1亿美元的IPO共19家，相应募资990.35亿，占全部42家IPO数量的45.2%、全部IPO募资的92.5%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/stockzmt/2025-07-04/doc-infehues7724473.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["00325","BK1233","BK1161","399300","BK1213","HEXmain","09887","BK1616","02589","BK1587","02617","159982","LU0211977185.USD"],"gpt_icon":1},{"id":"2548138506","title":"维立志博通过港交所聆讯，业绩持续亏损","url":"https://stock-news.laohu8.com/highlight/detail?id=2548138506","media":"新浪财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548138506?lang=zh_cn&edition=fundamental","pubTime":"2025-07-03 23:13","pubTimestamp":1751555604,"startTime":"0","endTime":"0","summary":"6月23日，南京维立志博生物科技股份有限公司通过港交所聆讯，并披露更新后的招股说明书。仅百济神州一家客户维立志博成立于2012年，是一家临床阶段生物科技公司，专注于肿瘤、自身免疫性疾病及其他重大疾病新疗法的发现、开发及商业化。招股说明书显示，维立志博仅有百济神州一家客户。维立志博2025年第一季度研发开支为5775万元，上年同期的研发开支为4327万元。公司提示风险称，在可预见的未来，公司预期将继续产生大量开支及亏损。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507032332299798c62a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507032332299798c62a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2328871848.SGD","80388","00388","LU0307460666.USD","LU1969619763.USD","BK1500","BK1583","LU0588546209.SGD","06160","BK1588","BK1161","BK1131","09887"],"gpt_icon":0},{"id":"2548605198","title":"211家公司排队港股IPO！超八成为首次递表，A股公司纷纷赴港交表","url":"https://stock-news.laohu8.com/highlight/detail?id=2548605198","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548605198?lang=zh_cn&edition=fundamental","pubTime":"2025-07-02 17:14","pubTimestamp":1751447640,"startTime":"0","endTime":"0","summary":"　　2025年上半年收官，港股IPO市场迎爆发式增长。　　2025年上半年，港股共有240家递表企业，主板上市231家，GEM上市9家，其中29家已完成上市。　　截至6月30日，仍在递表有效期的公司有211家，其中维立志博、明基医院2家公司已通过聆讯；　　此外，还有41家已经递表的A股公司，大多是信息技术行业。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/2025-07-02/doc-infeanhk2539688.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["HSTECH","YANG","07226","159982","HSCEI","BK4614","399300","09887"],"gpt_icon":1},{"id":"2548239160","title":"一图解码：港股IPO一周回顾 递表情绪高涨 单日递表量达16家","url":"https://stock-news.laohu8.com/highlight/detail?id=2548239160","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2548239160?lang=zh_cn&edition=fundamental","pubTime":"2025-07-01 10:47","pubTimestamp":1751338059,"startTime":"0","endTime":"0","summary":"…","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"netease_stock","url":"https://www.163.com/dy/article/K3CIGEFS0519QIKK.html","rn_cache_url":null,"customStyle":"","selectors":"article, body","filters":"","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.163.com/dy/article/K3CIGEFS0519QIKK.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"netease_stock","symbols":["09887"],"gpt_icon":0},{"id":"2547035640","title":"IPO周报｜本周1只新股申购，创业板迎电子树脂头部供应商","url":"https://stock-news.laohu8.com/highlight/detail?id=2547035640","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2547035640?lang=zh_cn&edition=fundamental","pubTime":"2025-06-30 08:00","pubTimestamp":1751241631,"startTime":"0","endTime":"0","summary":"本周新股申购迎来覆铜板领域电子树脂供应商的本土高新技术企业。同宇新材主营业务为电子树脂的研发、生产和销售，主要应用于覆铜板生产。据华金证券研报，同宇新材是领先的覆铜板领域电子树脂本土供应商，近年来产品销量在同行业内资企业中均名列前茅。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630080256a4c52246&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630080256a4c52246&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0175","09887","02648","159982","IE0005HP3H50.USD","399300","BK0214","BK0185","BK0201","BK0028","000001.SH","603186","159915","BK0188","603345","399006","688519","601127","600183"],"gpt_icon":0},{"id":"2545630281","title":"维立志博上市聆讯获通过","url":"https://stock-news.laohu8.com/highlight/detail?id=2545630281","media":"微博财经-财道工作室","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545630281?lang=zh_cn&edition=fundamental","pubTime":"2025-06-24 18:55","pubTimestamp":1750762500,"startTime":"0","endTime":"0","summary":"来源：@经济观察报微博公司动态6月23日，港交所披露，南京维立志博生物科技股份有限公司上市聆讯获通过，公司将登陆港交所主板上市，联席保荐人为摩根士丹利和中信证券。维立志博于2012年成立，是一家临床阶段生物科技公司，专注于肿瘤、自身免疫性疾病及其他重大疾病新疗法的发现、开发及商业化。目前，公司尚无产品获批进行商业销售，也未从产品销售中产生任何收入。在业绩记录期间，维立志博未实现盈利，存在经营亏损。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/wbstock/2025-06-24/doc-infcerue8890258.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["MUCmain","UCmain","CNHmain","CYB","09887","MCNHmain"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":52,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/09887\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"09887\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"09887\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/09887\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"09887","date":"2025-07-25","current":-39.760016,"percent":1,"low":-39.760016,"twenty":-39.760016,"median":-39.760016,"eighty":-39.760016,"high":-39.760016,"avg":-39.760016,"sd":0,"marketCap":12652000240},"quantilePoints":[{"date":"2025-07-25","current":-39.760016,"twenty":-39.760016,"median":-39.760016,"eighty":-39.760016,"marketCap":12652000240}],"updateTime":1753571613298}}}